The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Jazz Pharmaceuticals plc (NASDAQ: JAZZ) closed at $101.44 down -8.75% from its previous closing price of $111.17. In other words, the price has decreased by -$8.75 from its previous closing price. On the day, 3.08 million shares were traded.
Ratios:
For a deeper understanding of Jazz Pharmaceuticals plc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.43 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.60. For the most recent quarter (mrq), Quick Ratio is recorded 2.97 and its Current Ratio is at 3.38. In the meantime, Its Debt-to-Equity ratio is 1.29 whereas as Long-Term Debt/Eq ratio is at 1.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on March 07, 2025, Upgraded its rating to Buy and sets its target price to $179 from $145 previously.
Wells Fargo Upgraded its Equal Weight to Overweight on February 13, 2025, whereas the target price for the stock was revised from $130 to $170.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 01 ’25 when COZADD BRUCE C sold 1,000 shares for $116.35 per share. The transaction valued at 116,350 led to the insider holds 439,307 shares of the business.
COZADD BRUCE C sold 500 shares of JAZZ for $60,000 on May 02 ’25. The Chairman & CEO now owns 438,807 shares after completing the transaction at $120.00 per share. On May 01 ’25, another insider, COZADD BRUCE C, who serves as the Officer of the company, bought 1,500 shares for $117.57 each.
Valuation Measures:
As of this moment, Jazz’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.68, and their Forward P/E ratio for the next fiscal year is 4.68. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.10. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.54 while its Price-to-Book (P/B) ratio in mrq is 1.50.
Stock Price History:
Over the past 52 weeks, JAZZ has reached a high of $148.06, while it has fallen to a 52-week low of $95.49. The 50-Day Moving Average of the stock is -17.48%, while the 200-Day Moving Average is calculated to be -14.66%.
Shares Statistics:
A total of 61.63M shares are outstanding, with a floating share count of 58.83M. Insiders hold about 4.54% of the company’s shares, while institutions hold 95.27% stake in the company.
